Form 4: BIO-key International CEO and Chairman Acquires Company Stock

Sentiment:

Insider Transaction Report


Michael W. DePasquale, CEO and Chairman of BIO-key International, Inc., acquired 139 shares of common stock through the company's Employee Stock Purchase Plan.

Better than expectedThe acquisition of shares by a key executive, particularly the CEO and Chairman, is generally viewed as a positive signal of management's confidence in the company's valuation and future performance.

Summary

  • Michael W. DePasquale, who serves as Director, Chief Executive Officer, Chairman, and a 10% Owner of BIO-key International, Inc. (BKYI), acquired 139 shares of common stock.
  • The transaction occurred on June 30, 2025, with shares acquired at a price of $0.70 per share.
  • The acquisition was made under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan and is exempt under SEC Rules 16b-3(d) and 16b-3(c).
  • Following this transaction, Michael W. DePasquale directly beneficially owns 53,658 shares of common stock.
  • Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants.

Sentiment

Score: 7

Explanation: The sentiment is positive due to an insider acquisition, indicating management confidence. However, the relatively small number of shares acquired limits the overall impact on sentiment.

Positives

  • Acquisition of shares by a key executive, Michael W. DePasquale, indicates continued confidence in the company's future prospects.
  • The transaction was conducted under an Employee Stock Purchase Plan, which is a common mechanism for employee ownership and alignment of interests.

Future Outlook

NA

Industry Context

This insider transaction reflects a routine acquisition under an employee stock purchase plan, which is a common practice across various industries to encourage employee ownership and align interests with shareholders. It does not provide broader industry trend insights.

Related Party Transactions

  • The acquisition of shares by Michael W. DePasquale was conducted under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, which constitutes a transaction between an executive (related party) and the company.

Stakeholder Impact

  • Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.
  • Employees participating in the Employee Stock Purchase Plan benefit from the opportunity to acquire company stock at a potentially favorable price, aligning their financial interests with the company's performance.

Key Dates

DateDescription
06/30/2025Date of common stock acquisition by Michael W. DePasquale.
07/02/2025Date the Form 4 statement was signed and filed.

Keywords

BIO-key International, BKYI, SEC Form 4, Insider Trading, Stock Acquisition, Employee Stock Purchase Plan, Michael W. DePasquale, CEO, Chairman, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.